TOKYO -- Japan's Fujifilm Holdings will spend $1.6 billion (about 200 billion yen) to nearly quadruple its capacity for biopharmaceutical products by upgrading U.S. and European plants, Nikkei has learned.
Pharmaceuticals
Fujifilm to pump $1.6bn into biopharma in U.S. and Europe
Japan group to nearly quadruple capacity to meet rising demand for cancer drugs
Fujifilm will add equipment to its contract biopharmaceutical plants, such as this one in Denmark. (Photo courtesy of Fujifilm)
Read Next
Latest on Pharmaceuticals
